Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer

Li Song, Wenbin Yu, Fei Xie, +20

Nature Communications

Upregulation of programmed cell death ligand 1 promotes resistance response in non‐small‐cell lung cancer patients treated with neo‐adjuvant chemotherapy

Panpan Zhang, Yuanyuan Ma, Chao Lv, +10

Cancer Science

A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments

Yanmei Zhang, Qifan Hu, Yuquan Pei, +18

Nature Communications

Occult mediastinal lymph node metastasis in FDG‐PET/CT node‐negative lung adenocarcinoma patients: Risk factors and histopathological study

Miao Huang, Shaolei Li, Nan Li, +4

Thoracic Cancer

Aneuploid Circulating Tumor Cells as a Predictor of Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer

Miao Huang, Yuanyuan Ma, Chao Lv, +6

International Journal of General Medicine

Management of occult malignant pleural disease firstly detected at thoracotomy for non-small cell lung cancer patients

Shaolei Li, Shanyuan Zhang, Miao Huang, +2

Journal of Thoracic Disease

Clinical recommendations for perioperative immunotherapy‐induced adverse events in patients with non‐small cell lung cancer

Jun Ni, Miao Huang, Li Zhang, +1

Thoracic Cancer

Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion

Ruohao Zhang, Miao Huang, Hong Wang, +5

Pathology & Oncology Research